WHO suggests that molnupiravir is only provided to non-severe COVID-19 patients with the highest risk of hospitalization - e.g. people who have not received a #COVID19 vaccination, older people, people with immunodeficiencies & people living with chronic diseases like diabetes
https://twitter.com/WHO/status/1499399183832272900
As this is a new drug, WHO recommends active monitoring for drug safety, along with other strategies to mitigate potential harms
https://twitter.com/WHO/status/1499399183832272900
Children, pregnant and breastfeeding women should not be given the drug.
People who take molnupiravir should have a contraceptive plan. Health systems should ensure access to pregnancy testing and contraceptives at the point of care.
People who take molnupiravir should have a contraceptive plan. Health systems should ensure access to pregnancy testing and contraceptives at the point of care.
https://twitter.com/WHO/status/1499399183832272900
WHO also updates its recommendation on casirivimab-imdevimab, a monoclonal antibody cocktail.
Based on evidence that this combination of drugs is ineffective against the Omicron, WHO now recommends that it is only given when the #COVID19 infection is caused by another variant.
Based on evidence that this combination of drugs is ineffective against the Omicron, WHO now recommends that it is only given when the #COVID19 infection is caused by another variant.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
